← FDA Drug Approvals (Drugs@FDA)

METHAZOLAMIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TAGI · Approved 2022-10-18

Drug application

FDA Application #
ANDA215615
Application type
Abbreviated New Drug Application (Generic)
Brand name
METHAZOLAMIDE
Generic name
METHAZOLAMIDE
Active ingredients
METHAZOLAMIDE
Dosage form
TABLET
Route
ORAL
Marketing status
Prescription
Sponsor
TAGI
Manufacturer
Precision Dose, Inc.
First approval
2022-10-18

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown